Abstract PD5-04: An open-label, phase II basket study of olaparib and durvalumab (MEDIOLA): Updated results in patients with germlineBRCA-mutated (gBRCAm) metastatic breast cancer (MBC)

SM Domchek, S Postel-Vinay,S-A Im,Y Hee Park,J-P Delord,A Italiano,J Alexandre,B You,S Bastian,MG Krebs,S Waqar,M Lanasa,HK Angell,M Tang, C Gresty, L Opincar, P Herbolsheimer, B Kaufman

Poster Discussion Abstracts(2019)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要